The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
An evaluation of national treatment trends in pancreatic cancer.
Brian S. Seal
Employment or Leadership Position - Bayer
Stock Ownership - Bayer
Fang Xia
No relevant relationships to disclose
Rebecca Germino
No relevant relationships to disclose
Petra Rietschel
No relevant relationships to disclose
Carl V Asche
Research Funding - Bayer
Anna O. D'Souza
Research Funding - Bayer
Kellie Morland
Research Funding - Bayer
Michael Eaddy
Research Funding - Bayer